Showing results (531-540 of 3,408) with videos related to
Sort By:
Pageof 341
Chemosphere|June 22, 2021
The use of phosphonates in agriculture. Chemical, biological properties and legislative issuesMaria Chiara Manghi, Mauro Masiol, Riccardo Calzavara, et al.Plos One|May 18, 2019
Heart rate variability as a marker of recovery from critical illness in childrenLauren E Marsillio, Tomas Manghi, Michael S Carroll, et al.Vaccine|April 27, 2000
A possible explanation for the discrepancy between ELISA and neutralising antibodies to tetanus toxinJ Dokmetjian, C Della Valle, V Lavigne, et al.Critical Care Medicine|July 11, 2001
Macrophage migration inhibitory factor and innate immune responses to bacterial infectionsC Froidevaux, T Roger, C Martin, et al.Journal of Colloid and Interface Science|November 2, 2011
Self-assembly in surfactant-based liquid mixtures: octanoic acid/Bis(2-ethylhexyl)amine systemsPietro Calandra, Vincenzo Turco Liveri, Pietro Riello, et al.Physical Chemistry Chemical Physics : PCCP|May 29, 2019
Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS-PEO block copolymerDomenico Lombardo, Gianmarco Munaò, Pietro Calandra, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 15, 2009
A pharmacokinetic study of plerixafor in subjects with varying degrees of renal impairmentRonald MacFarland, Marjie L Hard, Robert Scarborough, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 1992
Evaluation of new anti-infective drugs for the treatment of osteomyelitis in adults. Infectious Diseases Society of America and the Food and Drug AdministrationJ T Mader, C Norden, J D Nelson, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 1992
Evaluation of new anti-infective drugs for the treatment of acute hematogenous osteomyelitis in children. Infectious Diseases Society of America and the Food and Drug AdministrationJ D Nelson, C Norden, J T Mader, et al.The European Respiratory Journal|October 2, 2004
Cost-effectiveness of full-course oral levofloxacin in severe community-acquired pneumoniaJ-B Wasserfallen, V Erard, A Cometta, et al.Pageof 341